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doi:10.1Objectives: The aim of this study was to investigate whether preoperative estimated left ventricular filling pres-
sure predicts the postoperative outcome in patients with severe aortic stenosis.
Methods: Two hundred ten patients who underwent isolated aortic valve replacement because of severe aortic
stenosis were analyzed. Left ventricular filling pressure was noninvasively assessed based on the ratio between
early diastolic mitral inflow and mitral annular velocity (E/E0), which was calculated based on results of mitral
inflow and mitral annular tissue Doppler scanning. Early postoperative hospital events were reviewed. Postoper-
ative mortality and morbidity were searched and compared according to left ventricular filling pressure.
Results: Preoperative functional class was associated with increased E/E0 values. Postoperative hospital events
were higher in patients with increased preoperative E/E0 values. Midterm mortality of the overall population was
very low after aortic valve replacement (2%). Cardiovascular event-free survival, including hospital visits caused
by heart failure symptoms, embolic cerebral infarction, and sudden cardiac death, was significantly lower in the
patients with increased left ventricular filling pressure and E/E0 values of greater than 12 (P¼ .03). Multivariable
analysis showed a high hazard ratio of increased E/E0 values of greater than 12 (hazard ratio, 41; P< .001).
Conclusions: The incidence of postoperative mortality after isolated aortic valve replacement caused by severe
aortic stenosis is relatively low in the current era. E/E0 representing diastolic filling pressure is the most important
preoperative predictor of risk of early postoperative hospital course and postoperative morbidity. (J Thorac Car-
diovasc Surg 2010;140:1361-6)P
MProlonged pressure overload in patients with severe aortic
stenosis (AS) induces remodeling of the left ventricle and
alteration of both systolic and diastolic function. As a result,
left ventricular (LV) filling pressure is commonly increased
in patients with severe AS.1,2 The increased filling pressure
results in pulmonary hypertension and dyspnea2 in this
patient population. However, most patients with increased
LV filling pressure in the setting of severe AS have a nor-
mal left ventricular ejection fraction (LVEF). It is also
likely that the increased filling pressure is partly related
to superimposed diastolic dysfunction independent of se-e Cardiovascular Imaging Center, Cardiac and Vascular Center,a and the
rtment of Thoracic and Cardiovascular Surgery,b Samsung Medical Center,
kyunkwan University School of Medicine, Seoul, Korea; and the Division
rdiovascular Diseases,c Mayo Clinic College of Medicine, Rochester, Minn.
ures: None.
d for publication July 21, 2009; revisions received Jan 12, 2010; accepted for
cation Feb 8, 2010; available ahead of print April 12, 2010.
for reprints: Jae K. Oh, MD, Division of Cardiovascular Diseases, Mayo
c College of Medicine, Gonda 6 South, 200 1st st SW, Rochester, MN
5 (E-mail: oh.jae@mayo.edu); and Pyo-Won Park, MD, Department of Tho-
and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan Uni-
y School of Medicine, 50 IL Won-Dong, Kangnam-Ku, Seoul, 135-230,
Korea (E-mail: pwpark@skku.edu).
23/$36.00
ht  2010 by The American Association for Thoracic Surgery
016/j.jtcvs.2010.02.022
The Journal of Thoracic and Carvere AS. After aortic valve replacement (AVR), LV after-
load rapidly decreases and LV function improves, but LV
filling pressure can remain increased in some patients for
years after surgical intervention and affects postoperative
outcomes.3,4
Increased LV filling pressure is associated with diastolic
dysfunction and hence is a reliable parameter to evaluate
LV diastolic dysfunction.5 Previous reports suggested that
diastolic dysfunction,6 pulmonary hypertension,7 and more
severe functional class4 were associated with poor patient
outcomes, and all of these factors can be explained by in-
creased LV filling pressure. Therefore the single parameter
of LV filling pressure might predict postoperative outcomes
after AVR because of severe AS.
The velocity of mitral annular motion can be easily mea-
sured online by using echocardiography with the Doppler
tissue-imaging technique. Because early diastolic velocity
of the mitral annulus is a relatively load-independent index
of LV relaxation and early mitral inflow velocity is associ-
ated with relaxation and LV filling pressure, the simple ratio
between early diastolic mitral inflow and mitral annular ve-
locity (E/E0) has been shown to be a reliable method for non-
invasive estimation of LV filling pressure.8,9 It is now
routinely used in clinical practice, including in patients
with moderate-to-severe AS.10 The primary aim of this studydiovascular Surgery c Volume 140, Number 6 1361
Abbreviations and Acronyms
AS ¼ aortic stenosis
AVR ¼ aortic valve replacement
E/E0 ¼ Ratio between early diastolic mitral inflow
and mitral annular velocity
LA ¼ left atrial
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
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vasively estimated LV filling pressure) predict postoperative
adverse outcomes in patients with severe AS.MATERIALS AND METHODS
Study Population
Two hundred forty-eight patients who underwent isolated AVR for de-
generative severe AS from January 2003 to December 2008 in Samsung
Medical Center were retrospectively reviewed. Patients who had rheumatic
AS, other severe valve diseases requiring a valve operation, and a history of
previous cardiac surgery or recent myocardial infarction in the last 6 months
were excluded from this study. Patients who presented with acute coronary
syndrome with left main disease or multivessel disease were also excluded.
Of the 248 patients, 210 who had complete preoperative echocardiographic
analysis, including tissue Doppler parameters, were our study subjects.
Hospital records were reviewed, and clinical variables, including age, sex,
cardiovascular risk factors, and/or other variables regarding AVR, were
investigated.
Echocardiographic Examination
Preoperative echocardiographic parameters were acquired from our elec-
tronic medical database. Preoperative echocardiographic analysis was usu-
ally performed within 2 weeks before the operation. As a routine protocol,
our laboratory measures LV systolic and diastolic dimensions, end-diastolic
LV wall thickness, LVEF, and pulsed-wave Doppler velocities of mitral
inflow. The LV mass index was calculated based on M-mode echocardio-
graphic analysis, as previously described,11 and the left atrial (LA) volume
index was calculated with the prolate–ellipsoid biplane method.12 Peak
early (E) and late (A) diastolic velocities of mitral inflow were measured
by using pulsed-wave Doppler scanning at the tip of the mitral valve leaflets.
Peak early (E0) and late (A0) diastolic mitral annular velocities were acquired
at the septum in the apical 4-chamber view. Aortic valve mean and peak
transvalvular gradients were calculated from the peak aortic valve Doppler
velocities interrogated from multiple transducer locations. Aortic valve area
was calculated by using the continuity equation.13
Outcome Measures
The postoperative hospital course was reviewed regarding in-hospital
cardiovascular events. In-hospital complications were divided into surgical
and cardiovascular complications. The former included wound problems,
including infection or bleeding and redo operations caused by technical
failure. Cardiovascular complications were defined as cerebral embolism,
cardiopulmonary resuscitation, and arrhythmia requiring cardioversion or
pacemaker insertion before discharge. If a cardiovascular complication
was associated with a surgical complication, that event was excluded
from the cardiovascular events. Early postoperative mortality was defined
as death within 30 days after AVR.
Postoperative outcomes and events after discharge were acquired from
the review of medical records, direct telephone interviews with patients or1362 The Journal of Thoracic and Cardiovascular Surtheir families, and national registry of birth and death data. Cause of death
was classified as cardiac (sudden death, heart failure, or myocardial infarc-
tion) or noncardiac. Cardiovascular events were defined as heart failure
requiring hospital admission or an early hospital visit, embolic cerebral in-
farction, or cardiac death during the follow-up period. This study protocol
for retrospective review and follow-up analysis was approved by our insti-
tutional review committee (Samsung Medical Center).
Statistical Analysis
Continuous variables are expressed as means  standard deviations.
Time variables were expressed as medians  interquartile ranges. Categor-
ical variables are expressed as numbers and percentages. For comparison
between 2 groups, the c2 test or Fisher’s exact test was used for categorical
variables, and the independent t test or Mann–Whitney test was applied for
continuous variables, where appropriate, according to normality. The opti-
mal cutoff value of E/E0 to predict postoperative morbidity was determined
by using receiver operating characteristic curve analysis. Postoperative
clinical outcomes were demonstrated by using the curve derived from the
Kaplan–Meier estimation method and were compared by with the log-
rank test. For multivariable analysis for cardiovascular events, the propor-
tional hazard assumption was tested with Schoenfeld residuals and the
Supremum test for proportional hazards assumption. Possible predictors
were tested by using Cox proportional hazard regression with the bootstrap-
ping method. Each proportional hazards model was subjected to 1000 boot-
strap replications by using random samples generated from and consisting
of the same number of patients as the original model. Bootstrap estimates
of hazard ratios and 95% confidence intervals were calculated by using
a bias-corrected method derived from the 1000 replications. All statistical
analyses were performed with the Statistical Analysis Software package
(SAS version 9.1, SAS Institute, Inc, Cary, NC).RESULTS
Patient Characteristics
Clinical and echocardiographic characteristics of the 210
patients are summarized in Table 1. The ethnicity of all the
patients was Korean. Severe dyspnea with New York Heart
Association functional class 3 or 4 was present in 22% of
the patients before AVR. LVEF was less than 50% in 18%
of the patients. The mean E/E0 value was increased at
16.8  8.6, and the LV mass index was increased at 151 g/
m2. E/E0 values were correlated with LVEF (r ¼ 0.34,
P< .001), aortic valve area (r ¼ 0.24, P ¼ .001), LV
mass index (r ¼ 0.23, P < .001), LA volume index
(r ¼ 0.42, P< .001), pulmonary hypertension (r ¼ 0.48,
P< .001), and the functional class of the patients (r ¼ 0.30,
P<.001). A history of coronary artery disease was presented
in 17% of the patients, and coronary artery bypass grafting
during AVR was performed in 11% of the patients.Postoperative Hospital Course
None of the patients experienced early postoperative
death within 30 days after AVR. Postoperative ventilator
time was 11.0  8.3 hours. Mean postoperative intensive
cardiac unit and hospital stays after valve surgery were
1.0  1.0 days and 8.0  3.0 days, respectively.
Postoperative surgical complications were present in 5
(2.3%) patients, and in-hospital cardiovascular complica-
tions were present in 13 (6.2%) patients (embolic cerebralgery c December 2010
TABLE 1. Characteristics of the study population
Values (n ¼ 210)
Age, y 64.6  10.0
Male sex, n (%) 136 (64.8)
Body surface area, m2 1.7  0.2
NYHA functional class 2.1  0.7
NYHA class III or IV, n (%) 46 (21.9)
Hypertension, n (%) 92 (43.8)
Diabetes mellitus, n (%) 36 (17.1)
Smoking, n (%) 79 (37.6)
History of CAD, n (%) 36 (17.1)
End-systolic dimension, mm 33.9  8.6
End-diastolic dimension, mm 54.0  7.4




Left ventricular mass index, g/m2 151.4  43.0
LA volume index, mL/m2 38.6  14.6
E/E0 16.8  8.6




Tricuspid/bicuspid/unicuspid 69 (32.9)/141 (67.1)/0 (0)
Aortic valve area, cm2 0.71  0.16
Mean transvalvular gradient, mm Hg 57.1  17.0
Aortic prosthesis type, n (%)
Mechanical 71 (33.8)
Bioprosthesis 139 (66.2)
Aortic prosthetic size, mm 22.3  1.8
Associated coronary artery
bypass graft, n (%)
22 (10.5)
Preoperative medication, n (%)
Statin 82 (39.0)
ACE inhibitor or ARB 70 (33.3)
b-Blocker 60 (28.6)
Calcium-channel blocker 43 (20.5)
NYHA, New York Heart Association; CAD, coronary artery disease; LA, left atrial; E/
Ee, ratio between early diastolic mitral inflow and mitral annular velocity; ACE,
angiotensin-converting enzyme; ARB, angiotensin receptor blocker. *Peak systolic
pulmonary arterial pressure was available only in 163 patients because reliable tracing
of tricuspid regurgitation Doppler scanning was impossible.
FIGURE1. In-hospital cardiovascular complications according to the ratio
between early diastolic mitral inflow and mitral annular velocity (E/E0).
Postoperative cardiovascular complications, including embolic cerebral
infarction, cardiopulmonary resuscitation, and arrhythmia requiring cardio-
version or pacemaker insertion, occurred in patients with E/E0 values of
greater than 12 (P< .05), suggesting increased left ventricular filling pres-
sure before surgical intervention.
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Minfarction in 2, transient ischemic accident in 1, intraopera-
tive intra-arterial balloon pump in 1, cardiopulmonary resus-
citation or cardioversion caused by clinically significant
arrhythmia resulting in sudden collapse in 7, pacemaker in-
sertion during surgical intervention caused by atrioventricu-
lar block in 1, and pericardiocentesis caused by pericardial
effusion in 1). Cardiovascular complications were more
prevalent in patients with preoperative E/E0 values of greater
than 12 (Figure 1).
Midterm Morbidity and Mortality
All-cause mortality was confirmed in the entire study pop-
ulation as follows. Telephone or outpatient interviews were
performed with 97.1% (n¼ 204) of the patients or their first-
degree relatives to confirm themortality andmorbidity of theThe Journal of Thoracic and Carpatients. The mortality of the rest of the patients (2.9%,
n ¼ 6), who could not be reached by telephone, was con-
firmed by using national registry of death and survival data.
The median follow-up duration was 25.39 16.2 months.
Four (1.8%) patients died during follow-up (Figure 2).
Among them, cardiovascular mortality occurred in 2 pa-
tients. Cardiovascular events were more prevalent in the pa-
tients with high E/E0 values in the overall study population
(Figure 3, A). Fourteen (10.1%) of the patients with E/E0
values of greater than 12 (n ¼ 72) had morbidity of cardio-
vascular events, but only 2 (2.8%) of the patients with E/E0
values of 12 or less (n¼ 138) had cardiovascular events dur-
ing the follow-up period (P¼ .03; Figure 3, A). This finding
persisted among the patients with preserved LVEF (LVEF
>50%, P ¼ .04; Figure 3, B). Multivariable analysis using
Cox proportional hazard regression with the bootstrapping
method also showed a significantly high hazard ratio with in-
creased E/E0 values of greater than 12 (Table 2).
DISCUSSION
In this study postoperative outcome of isolated AVR be-
cause of severe AS was excellent, with a very low mortality
rate. Average preoperatively estimated LV filling pressure,
as determined by means of Doppler echocardiographic anal-
ysis, was increased in patients with severe AS. Midterm
mortality was excellent, but postoperative cardiovasculardiovascular Surgery c Volume 140, Number 6 1363
FIGURE 2. Survival curve after aortic valve replacement (AVR). The Ka-
plan–Meier survival curve shows excellent postoperative outcome with
very low midterm mortality (median follow-up duration, 25.39  16.2
months). Only 4 (1.8%) patients died during follow-up.
FIGURE 3. Event-free survival after aortic valve replacement (AVR). A,
The cardiovascular event-free survival curve shows a significantly higher
incidence of cardiovascular events with an increased ratio between early di-
astolic mitral inflow and mitral annular velocity (E/E0) values. B, Differ-
ences in event-free survival according to the estimated left ventricular
filling pressure was also observed in the patients with preserved left ventric-
ular ejection fractions.
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preoperative LV filling pressures (E/E0>12). On the other
hand, early postoperative outcomes were not related to the
preoperative aortic valve gradients or area.
Outcome of Isolated AVR in Patients With
Degenerative AS
Early postoperative mortality has decreased14 with
improvement in surgical techniques and perioperative care.
In-hospital mortality of isolated AVR varies according to
the study group, but it is usually less than 5%,15–17 and
midterm mortality has been reported to be less than
10%.18 In our clinical experience there was no in-hospital
mortality, and the midterm mortality was only 3% of overall
patients. Our excellent postoperative outcome can be ex-
plained by the characteristics of our study population, all
of whom are Korean. Our study population is younger,
and the percentage of bicuspid aortic valve was higher
than in other previous studies,3 which were mainly reported
from Western countries. Moreover, the prevalence of
coronary artery disease is much lower than that of other pre-
vious studies16,18 because of less prevalent atherosclerosis in
the Asian population.19
Preoperative LV Filling Pressure as a Risk for
Postoperative Outcomes
LVEF and cardiac symptoms have been used to determine
the timing of valvular surgery, especially in patients with
AS.20 This guideline is easy to use and supported by much
clinical data.21,22 Still, there are debates on the right
timing of AVR. Even though the presence of symptoms is
a definite predictor of poor outcome,23 patients might not
be aware of the fact that they are limited clinically, and fur-1364 The Journal of Thoracic and Cardiovascular Surthermore, symptoms are not specific. Moreover, symptoms
are sometimes insidious and are not easily elicited by physi-
cians. We might need to perform exercise testing to assess
the patient’s functional status.24 Even when AVR is per-
formed according to the guidelines, persistent or recurrent
heart failure can be observed after successful AVR, and per-
sistent heart failure has been reported to be present in 10%
of patients 5 years after AVR.4 Therefore we need more ob-
jective parameters to discriminate the high-risk patients who
are at risk of postoperative heart failure.
Increased LV filling pressure is a common pathophysiol-
ogy of pulmonary congestion in patients with heart failure,5gery c December 2010
TABLE 2. Preoperative risk factors for postoperative cardiovascular
events
Variables Hazard ratio 95% CI P value
Age, y 1.0 0.96–1.07 .63
Aortic valve area, cm2 17.0 0.96–300.2 .06
LV ejection fraction,% 1.0 0.94–1.08 .53
LV mass index, g/m2 1.0 0.98–1.00 .11
E/E0>12 40.8 39.00–41.68 <.001
CI, Confidence interval; LV, left ventricle; E/Et, ratio between early diastolic mitral in-
flow and mitral annular velocity.
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has been shown to be positively correlated with the func-
tional class of the patients and the development of pulmonary
hypertension,2 which was also demonstrated in our study
population. A prolonged increase in LV filling pressure pro-
motes LA remodeling,25 which can be a substrate of atrial fi-
brillation and a source of embolism.26 Furthermore,
myocardial fibrosis is an important pathology of the myocar-
dium with diastolic dysfunction and LV filling pressure, and
it can be a substrate for ventricular arrhythmia or conduction
abnormality. In our study subjects fatal arrhythmias were
more common in the patients with increased preoperative
LV filling pressure, which can be associated with increased
LV fibrosis and LA remodeling. The fact that E/E0 values
were not well correlated with the severity of AS using aortic
valve pressure gradient and aortic valve area suggests that the
increased preoperative LV filling pressure in patients with
severe AS is not all from AS but also from independent,
superimposed diastolic dysfunction. Increased LV filling
pressure has been predictive of poor long-term outcome in
patients with other conditions, such as diastolic heart failure,
systolic heart failure, and acute myocardial infarction.27 In
our study population cardiovascular events, including ar-
rhythmia requiring resuscitation and embolic cerebral infarc-
tion, were more common in the patients with preoperatively
increased LV filling pressure. After discharge, recurrent
heart failure was more common in patients with preopera-
tively increased LV filling pressure. This phenomenon was
also found in patients with preserved LVEF before AVR.
From our results, preoperative LV filling pressure did not
affect the mortality of the patients undergoing isolated AVR
but was associated with postoperative hospital course and
postoperative morbidity. We also suggest that noninvasive
measurements of LV filling pressure preoperatively can be
a prognostic indicator of midterm cardiovascular events after
isolated AVR in patients with severe AS, even in the setting
of preserved LVEF. Postoperative E/E0 values would be
beneficial also for follow-up of longer-term outcome of the
patients after AVR, which requires further study. The useful-
ness of LV filling pressure to determine the timing of the
AVR in asymptomatic patients with severe AS is beyond
our scope, but from our results, LV filling pressure deserves
a serious consideration as a marker to identify the high-riskThe Journal of Thoracic and Cargroup in future clinical investigations of valvular heart
diseases.Study Limitations
Our study has several limitations. First, the preoperative
and perioperative characteristics of our study population
were collected in a retrospective manner, but our echocar-
diographic performance has been standardized since 2003
and recorded in an electronic database, which minimizes
possible errors in data collection.
Second, our study population, all of whom are Korean, has
relatively low risk compared with those of other previous
studies fromWestern countries28; our data were not powered
to address any association with mortality, and the effect of
LV filling pressure onmorbidity after AVRmight not be gen-
eralized. However, the predictive value of E/E0 has been val-
idated in other conditions in other ethnic populations.
Third, LV filling pressure was not acquired by means of
invasive cardiac catheterization but assumed based on E/E0
values by using echocardiographic analysis. E/E0 values can
be influenced by LA pressure29 or LV systolic and diastolic
pressure30,31 and thus have the possibility of being
confounded. However, LV filling pressure in patients with
AS has been reported to be well correlated with LV filling
pressure measured by means of invasive methods.10,32
Moreover, although cardiac catheterization is relatively safe,
it remains an invasive procedure and is associated with
measurable risk. In this context noninvasive measurement of
LV filling pressure might be a safer method in routine
clinical practice.CONCLUSIONS
The incidence of early postoperative and midterm mortal-
ity after isolated AVR caused by severe AS is relatively low
in the current era. Still, increased LV filling pressure mea-
sured by using echocardiographic analysis is associated
with increased preoperative symptoms and early postopera-
tive morbidity in patients with severe AS. Increased LV fill-
ing pressure did not increase mortality after AVR but was
associated with midterm cardiovascular events. The aortic
valve gradient and area were not related to the preoperative
symptoms and postoperative clinical outcomes in patients
with severe AS.
Multivariable analysis with the bootstrap method was techni-
cally supported by the biostatistics team, Samsung Biomedical
Research Institute, Korea.References
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